The recent findings in two parallel Genome-Wide Association Studies (GWAS), identifying risk loci for CH, highlighted a strong association with a locus at chromosome 2q13 which harbours the MER proto-oncogene, tyrosine kinase (MERTK) gene [11, 12]. This evidence concerns the gene MERTK and cyclic hematopoiesis.